Literature DB >> 19870226

CHEMOIMMUNOLOGICAL STUDIES ON THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS : I. THE ISOLATION AND PROPERTIES OF THE ACETYL POLYSACCHARIDE OF PNEUMOCOCCUS TYPE I.

O T Avery1, W F Goebel.   

Abstract

The soluble specific substance of Pneumococcus Type I has been chemically isolated from the bacterial cells and from autolyzed cultures as an acetyl polysaccharide. So far as could be determined by the methods employed, the acetyl polysaccharide in highly purified form absorbs from Type I antipneumococcus serum all demonstrable type-specific precipitins, agglutinins and protective antibodies. Mice injected intraperitoneally with minute quantities of the acetyl polysaccharide develop active immunity to subsequent infection with Pneumococcus Type I. The immunity thus induced is type-specific. In several instances purpura has been observed in mice following the injection of larger amounts of the acetyl polysaccharide. Under the experimental conditions of this study, no type-specific precipitins, agglutinins or protective antibodies were demonstrable in the serum of rabbits following repeated intravenous injections of the Type I acetyl polysaccharide. The treated rabbits were not immune to subsequent infection with Pnemnococcus Type I. The acetyl polysaccharide is readily converted into its deacetylated derivative by treatment with dilute alkali. The chemical and immunological properties of the deacetylated polysaccharide are identical with those of the soluble specific substance in the chemical form in which it was originally isolated; the deacetylated form of the specific carbohydrate is non-antigenic, does not produce purpura in mice, and only incompletely absorbs the type-specific antibodies from Type I antipneumococcus serum. The immunological significance of the acetyl polysaccharide and its possible relationship to the specific substances isolated from Pneumococcus Type I by other workers are discussed.

Entities:  

Year:  1933        PMID: 19870226      PMCID: PMC2132296          DOI: 10.1084/jem.58.6.731

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  11 in total

1.  THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS : SECOND PAPER.

Authors:  M Heidelberger; O T Avery
Journal:  J Exp Med       Date:  1924-08-31       Impact factor: 14.307

2.  THE IMMUNIZING ANTIGEN OF THE PNEUMOCOCCUS : III. THE PURIFICATION OF THE WATER-SOLUBLE ANTIGEN.

Authors:  W A Perlzweig; C S Keefer
Journal:  J Exp Med       Date:  1925-11-30       Impact factor: 14.307

3.  THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS.

Authors:  M Heidelberger; O T Avery
Journal:  J Exp Med       Date:  1923-06-30       Impact factor: 14.307

4.  ON THE PRESENCE IN ANTIPNEUMOCOCCUS SERUM OF TYPE-SPECIFIC PROTECTIVE ANTIBODY NOT NEUTRALIZED BY HOMOLOGOUS SPECIFIC SOLUBLE SUBSTANCE.

Authors:  A B Sabin
Journal:  J Exp Med       Date:  1931-01-01       Impact factor: 14.307

5.  AN EXAMINATION OF THE MECHANISM OF PNEUMOCOCCUS IMMUNITY BY MEANS OF BACTERICIDAL MEASUREMENTS : II. THE REACTION BETWEEN THE ANTICARBOHYDRATE ANTIBODY AND TYPE-SPECIFIC PRODUCTS OF THE ORGANISM.

Authors:  H K Ward
Journal:  J Exp Med       Date:  1932-03-31       Impact factor: 14.307

6.  THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS : THIRD PAPER.

Authors:  M Heidelberger; W F Goebel; O T Avery
Journal:  J Exp Med       Date:  1925-10-31       Impact factor: 14.307

7.  A NOTE ON THE SPECIFIC AGGLUTINATION OF PNEUMOCOCCUS TYPES I, II AND III.

Authors:  J F Enders
Journal:  J Exp Med       Date:  1932-01-31       Impact factor: 14.307

8.  EXPERIMENTAL INTRADERMAL PNEUMOCOCCUS INFECTION IN RABBITS.

Authors:  K Goodner
Journal:  J Exp Med       Date:  1928-06-30       Impact factor: 14.307

9.  STUDIES ON PNEUMOCOCCUS IMMUNITY : III. THE NATURE OF PNEUMOCOCCUS ANTIGEN.

Authors:  W A Perlzweig; G I Steffen
Journal:  J Exp Med       Date:  1923-07-31       Impact factor: 14.307

10.  A TYPE SPECIFIC SUBSTANCE DISTINCT FROM THE SPECIFIC CARBOHYDRATE IN PNEUMOCOCCUS TYPE I.

Authors:  J F Enders
Journal:  J Exp Med       Date:  1930-07-31       Impact factor: 14.307

View more
  36 in total

1.  A scalable method for O-antigen purification applied to various Salmonella serovars.

Authors:  F Micoli; S Rondini; M Gavini; I Pisoni; L Lanzilao; A M Colucci; C Giannelli; F Pippi; L Sollai; V Pinto; F Berti; C A MacLennan; L B Martin; A Saul
Journal:  Anal Biochem       Date:  2012-11-07       Impact factor: 3.365

2.  Phase 1 and phase 2 studies of Salmonella enterica serovar paratyphi A O-specific polysaccharide-tetanus toxoid conjugates in adults, teenagers, and 2- to 4-year-old children in Vietnam.

Authors:  E Y Konadu; F Y Lin; V A Hó; N T Thuy; P Van Bay; T C Thanh; H B Khiem; D D Trach; A B Karpas; J Li; D A Bryla; J B Robbins; S C Szu
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

Review 3.  Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA).

Authors:  D E Briles; R C Tart; E Swiatlo; J P Dillard; P Smith; K A Benton; B A Ralph; A Brooks-Walter; M J Crain; S K Hollingshead; L S McDaniel
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132

4.  ON THE USE OF ADSORBENTS IN IMMUNIZATIONS WITH HAPTENS.

Authors:  J Jacobs
Journal:  J Exp Med       Date:  1934-03-31       Impact factor: 14.307

5.  THE IMMUNOLOGICAL SPECIFICITY OF STAPHYLOCOCCI : III. INTERRELATIONSHIPS OF CELL CONSTITUENTS.

Authors:  L A Julianelle; C W Wieghard
Journal:  J Exp Med       Date:  1935-06-30       Impact factor: 14.307

6.  THE ISOLATION OF THE BLOOD GROUP A SPECIFIC SUBSTANCE FROM COMMERCIAL PEPTONE.

Authors:  W F Goebel
Journal:  J Exp Med       Date:  1938-07-31       Impact factor: 14.307

7.  Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein A (PspA).

Authors:  L S McDaniel; J Yother; M Vijayakumar; L McGarry; W R Guild; D E Briles
Journal:  J Exp Med       Date:  1987-02-01       Impact factor: 14.307

8.  THE INFLUENCE OF INFLAMMATION ON THE ABSORPTION OF SUBSTANCES OF VARIED DIFFUSIBILITY.

Authors:  R G Miller
Journal:  J Exp Med       Date:  1938-03-31       Impact factor: 14.307

9.  Polysaccharide in delayed hypersensitivity. I. Pneumococcal polysaccharide as inducer and elicitor of delayed reactivity in guinea pigs.

Authors:  R J Gerety; R W Ferraresi; S Raffel
Journal:  J Exp Med       Date:  1970-01-01       Impact factor: 14.307

10.  IMPROVED METHODS FOR THE PREPARATION OF THE SPECIFIC POLYSACCHARIDES OF PNEUMOCOCCUS.

Authors:  M Heidelberger; C M Macleod; H Markowitz; A S Roe
Journal:  J Exp Med       Date:  1950-03-31       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.